J 2023

Preparticipation Screening of Athletes: The Prevalence of Positive Family History

BOGNA, Jiravska Godula, Otakar JIRAVSKÝ, Petra PESOVA, Libor JELINEK, Marketa SOVOVA et. al.

Basic information

Original name

Preparticipation Screening of Athletes: The Prevalence of Positive Family History

Authors

BOGNA, Jiravska Godula (203 Czech Republic), Otakar JIRAVSKÝ (203 Czech Republic, guarantor, belonging to the institution), Petra PESOVA (203 Czech Republic), Libor JELINEK (203 Czech Republic), Marketa SOVOVA (203 Czech Republic), Katarina MORAVCOVA (203 Czech Republic), Jaromir OZANA (203 Czech Republic), Miroslav HUDEC (203 Czech Republic, belonging to the institution), Roman MIKLÍK (203 Czech Republic, belonging to the institution), Jan HECKO (203 Czech Republic), Libor SKNOURIL (203 Czech Republic) and Eliska SOVOVA (203 Czech Republic)

Edition

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, Basel, MDPI, 2023, 2308-3425

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.400 in 2022

RIV identification code

RIV/00216224:14110/23:00133336

Organization unit

Faculty of Medicine

UT WoS

000977794700001

Keywords in English

sudden cardiac death; athlete; preparticipation screening

Tags

Tags

International impact, Reviewed
Změněno: 31/1/2024 09:39, Mgr. Tereza Miškechová

Abstract

V originále

Sudden cardiac death (SCD) is a leading cause of death among athletes, and those with a positive family history (FH) of SCD and/or cardiovascular disease (CVD) may be at increased risk. The primary objective of this study was to assess the prevalence and predictors of positive FH of SCD and CVD in athletes using four widely used preparticipation screening (PPS) systems. The secondary objective was to compare the functionality of the screening systems. In a cohort of 13,876 athletes, 1.28% had a positive FH in at least one PPS system. Multivariate logistic regression analysis identified the maximum heart rate as significantly associated with positive FH (OR = 1.042, 95% CI = 1.027-1.056, p < 0.001). The highest prevalence of positive FH was found using the PPE-4 system (1.20%), followed by FIFA, AHA, and IOC systems (1.11%, 0.89%, and 0.71%, respectively). In conclusion, the prevalence of positive FH for SCD and CVD in Czech athletes was found to be 1.28%. Furthermore, positive FH was associated with a higher maximum heart rate at the peak of the exercise test. The findings of this study revealed significant differences in detection rates between PPS protocols, so further research is needed to determine the optimal method of FH collection.